Ming‐Chin Yu

5.9k total citations · 1 hit paper
131 papers, 3.3k citations indexed

About

Ming‐Chin Yu is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Ming‐Chin Yu has authored 131 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hepatology, 50 papers in Surgery and 28 papers in Epidemiology. Recurrent topics in Ming‐Chin Yu's work include Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Liver Disease Diagnosis and Treatment (20 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers). Ming‐Chin Yu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Liver Disease Diagnosis and Treatment (20 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers). Ming‐Chin Yu collaborates with scholars based in Taiwan, United States and China. Ming‐Chin Yu's co-authors include Kun‐Ming Chan, Sen‐Yung Hsieh, Miin‐Fu Chen, Wei‐Chen Lee, Chao‐Wei Lee, Chen‐Fang Lee, Wei‐Chen Lee, Hong‐Shiue Chou, Ta‐Sen Yeh and Myron J. Tong and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ming‐Chin Yu

127 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia

2017 279 citations Ming‐Chin Yu, Sen‐Yung Hsieh et al. profile →

Peers

Countries citing papers authored by Ming‐Chin Yu

Since Specialization

Citations

This map shows the geographic impact of Ming‐Chin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Chin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Chin Yu more than expected).

Fields of papers citing papers by Ming‐Chin Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Chin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Chin Yu. The network helps show where Ming‐Chin Yu may publish in the future.

Co-authorship network of co-authors of Ming‐Chin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Chin Yu. A scholar is included among the top collaborators of Ming‐Chin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Chin Yu. Ming‐Chin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure‐Based Virtual Screening 2025 ·Advanced Science ·Chunlin Yang, (unknown), Huang‐Ju Tu, (unknown), Tony Eight Lin, (unknown), Mu‐Chun Li, (unknown), Jui‐Hua Hsieh, Ming‐Chin Yu, Sen‐Yung Hsieh, Hsing‐Pang Hsieh, Shiow‐Lin Pan, Kai‐Cheng Hsu	0
2	Gadolinium vanadate nanoparticles modified screen-printed carbon electrode for the electrochemical detection of furaltadone 2025 ·Electrochimica Acta ·(unknown), (unknown), Sivaprakash Sengodan, Elayappan Tamilalagan, Tse‐Wei Chen, Chen‐Chi Wang, Ming‐Chin Yu, (unknown), (unknown)	1
3	NRF2-SOX4 complex regulates PSPH in hepatocellular carcinoma and modulates M2 macrophage differentiation 2025 ·Cancer Gene Therapy ·Chi‐Neu Tsai, Ming‐Chin Yu, Yun‐Shien Lee, (unknown), (unknown), (unknown), Mei‐Ling Cheng, Sey‐En Lin, (unknown), (unknown), (unknown)	2
4	Boosting Sensitivity with Holmium Tungstate/Reduced Graphene Oxide composites for Electrochemical Detection of Mesalamine 2025 ·Chemical Engineering Journal ·(unknown), (unknown), Tse-Wei Chen, Shen–Ming Chen, Ramachandran Balaji, Elayappan Tamilalagan, Chen‐Chi Wang, Narendhar Chandrasekar, Ming‐Chin Yu, (unknown)	1
5	Three-dimensional flower-like strontium doped zinc oxide decorated with carbon black modified glassy carbon electrode for the detection of strychnine 2024 ·Journal of Alloys and Compounds ·(unknown), (unknown), (unknown), Tse-Wei Chen, Shen–Ming Chen, Ming‐Chin Yu, (unknown), (unknown), Subramanian Sakthinathan, Te‐Wei Chiu	3
6	Do low skeletal muscle bulk and disturbed body fat mass impact tumor recurrence in stage I/II hepatocellular carcinoma undergoing surgery? An observational cohort study 2024 ·International Journal of Surgery ·Chao‐Wei Lee, Hsin‐I Tsai, (unknown), Ming‐Chin Yu, Wei‐Chen Lee, (unknown), (unknown), Cheng‐Yu Lin, Mei‐Ling Cheng, Chi-Jen Lo, (unknown), (unknown)	2
7	Sensitive detection of cardiac glycoside digoxin based on sheet like structured cerium manganese oxide electrocatalyst 2024 ·Colloids and Surfaces A Physicochemical and Engineering Aspects ·(unknown), (unknown), (unknown), Tse-Wei Chen, Shen‐Ming Chen, Elayappan Tamilalagan, Ming‐Chin Yu	2
8	Absence of Survival Impact from Hepatitis During Immunotherapy in 193 Patients with Advanced Hepatocellular Carcinoma – An Observational Study from Taiwan 2024 ·Journal of Hepatocellular Carcinoma ·(unknown), (unknown), (unknown), (unknown), Shi‐Ming Lin, Chao‐Wei Lee, Ming‐Chin Yu, Wei‐Chen Lee, (unknown), Chia‐Hsun Hsieh	0
9	Enhanced electrochemical detection of sorafenib, an anticancer drug via CoGd-LDH modified glassy carbon electrode 2023 ·Process Safety and Environmental Protection ·(unknown), (unknown), Shen‐Ming Chen, (unknown), (unknown), Ming‐Chin Yu	12
10	Real-time detection of sorafenib in human serum samples: An evaluation study via electrochemical sensing probe fabricated with silver stannate 2023 ·Journal of the Taiwan Institute of Chemical Engineers ·Nandini Nataraj, (unknown), Tse-Wei Chen, Shen‐Ming Chen, (unknown), Ming‐Chin Yu, (unknown)	14
11	Gadolinium Manganese Oxide Nanorod Catalyst via a Facile Hydrothermal Approach: Application for Voltammetric Sensing of Antibiotic Drug Rifampicin in Pharmaceutical and Biological Samples 2022 ·Journal of The Electrochemical Society ·(unknown), N. Manjula, Tse‐Wei Chen, Shen‐Ming Chen, Wedad A. Al-onazi, Amal M. Al‐Mohaimeed, (unknown), Chun‐Wei Huang, Ming‐Chin Yu, Mohamed S. Elshikh	5
12	A Retrospective Comparison of Three Patient-Controlled Analgesic Strategies: Intravenous Opioid Analgesia Plus Abdominal Wall Nerve Blocks versus Epidural Analgesia versus Intravenous Opioid Analgesia Alone in Open Liver Surgery 2022 ·Biomedicines ·Hsin‐I Tsai, (unknown), (unknown), Ming‐Chin Yu, An‐Hsun Chou, Cheng‐Han Lee, (unknown), Jr‐Rung Lin, (unknown), Li‐Ling Chang, Chao‐Wei Lee	1
13	Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma 2022 ·Biomedicines ·(unknown), (unknown), (unknown), (unknown), Kuang‐Tse Pan, Chien‐Fu Hung, Tsung‐Han Wu, Chao‐Wei Lee, Chia‐Hsun Hsieh, (unknown), (unknown), Ming‐Chin Yu	4
14	SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo 2020 ·Oncogene ·Chi‐Neu Tsai, (unknown), (unknown), (unknown), Chun‐Hsin Wu, Sey‐En Lin, (unknown), (unknown), Sen‐Yung Hsieh, Ming‐Chin Yu	51
15	CLIC1 recruits PIP5K1A/C to induce cell-matrix adhesions for tumor metastasis 2020 ·Journal of Clinical Investigation ·Jei‐Ming Peng, (unknown), Ming‐Chin Yu, Sen‐Yung Hsieh	50
16	Percentage genome change and chromosome 7q amplification predict sorafenib response in advanced hepatocellular carcinoma 2020 ·Biomedical Journal ·Ming‐Chin Yu, Tsung‐Han Wu, Chao‐Wei Lee, Yun‐Shien Lee, (unknown), Chia-Lung Tsai, Sen‐Yung Hsieh, Chi‐Neu Tsai	2
17	Functional Genomics Identifies Hepatitis-Induced STAT3–TYRO3–STAT3 Signaling as a Potential Therapeutic Target of Hepatoma 2019 ·Clinical Cancer Research ·(unknown), (unknown), Ming‐Chin Yu, (unknown), Tse‐Ching Chen, Wen‐Yu Chuang, (unknown), Chen‐Chun Lin, Shi‐Ming Lin, Sen‐Yung Hsieh	13
18	Incorporation of biochemical factors for survival analysis of transarterial chemoembolization in patients with hepatocellular carcinoma: A retrospective cohort study 2019 ·Journal of International Medical Research ·(unknown), (unknown), Chao‐Wei Lee, Tsung‐Han Wu, (unknown), Shi‐Ming Lin, Ming‐Chin Yu, Chien‐Fu Hung	1
19	Bioinformatics microarray analysis and identification of gene expression profiles associated with cirrhotic liver 2016 ·The Kaohsiung Journal of Medical Sciences ·Kun‐Ming Chan, Tsung‐Han Wu, Ting‐Jung Wu, Hong‐Shiue Chou, Ming‐Chin Yu, Wei‐Chen Lee	10
20	Dubin-Johnson Syndrome with Cholelithiasis: Report of a Case 2010 ·Formosan Journal of Surgery ·I-Ming Kuo, Shang‐Yu Wang, Ming‐Chin Yu, Tse‐Ching Chen, Frank Wang, Yi-Yin Jan	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact